Publication Name	World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID	98146
Country	India

Received	2024-06-18 22:36
Peer-Review Started	2024-06-18 22:36
To Make the First Decision
Return for Revision	2024-07-05 02:41
Revised	2024-08-06 12:16
Second Decision	2024-09-10 02:49
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-09-10 09:45
Articles in Press	2024-09-10 09:45
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-09-14 14:42
Typeset the Manuscript	2024-09-23 07:16
Publish the Manuscript Online	2024-10-25 03:02

ISSN	2150-5349 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Insights of gut-liver axis in hepatic diseases: Mechanisms, clinical implications and therapeutic potentials
Manuscript Source	Invited Manuscript
All Author List	Naveen Jeyaraman, Madhan Jeyaraman, Tejaswin Mariappan, Sathish Muthu, Swaminathan Ramasubramanian, Shilpa Sharma, Gabriel Silva Santos, Lucas Furtado da Fonseca and José Fábio Lana
Funding Agency and Grant Number
Corresponding Author	Madhan Jeyaraman, MS, PhD, Assistant Professor, Research Associate, Department of Orthopaedics, ACS Medical College and Hospital, Dr MGR Educational and Research Institute, Velappanchavadi, Chennai 600077, Tamil Nadu, India. madhanjeyaraman@gmail.com
Key Words	Gut-liver axis; Dysbiosis; Liver disease; Probiotics; Fecal microbiota transplantation; Precision medicine
Core Tip	We explore the bidirectional impact of gut-liver interactions on liver disease, highlighting how gut microbiota metabolites affect metabolism. It suggests that altering gut microbiota composition could unveil new treatments for liver ailments. Future cohort studies using pan-omics will be crucial in understanding gut microbiome links to liver disease progression and finding effective interventions.
Publish Date	2024-10-25 03:02
Citation	<p>Jeyaraman N, Jeyaraman M, Mariappan T, Muthu S, Ramasubramanian S, Sharma S, Santos GS, da Fonseca LF, Lana JF. Insights of gut-liver axis in hepatic diseases: Mechanisms, clinical implications and therapeutic potentials. <i>World J Gastrointest Pharmacol Ther</i> 2024; 15(6): 98146</p>
URL	https://www.wjgnet.com/2150-5349/full/v15/i6/98146.htm
DOI	https://dx.doi.org/10.4292/wjgpt.v15.i6.98146

Full Article (PDF)	WJGPT-15-98146-with-cover.pdf
Manuscript File	98146_Auto_Edited_023716.docx
Answering Reviewers	98146-answering-reviewers.pdf
Audio Core Tip	98146-audio.mp3
Conflict-of-Interest Disclosure Form	98146-conflict-of-interest-statement.pdf
Copyright License Agreement	98146-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	98146-non-native-speakers.pdf
Peer-review Report	98146-peer-reviews.pdf
Scientific Misconduct Check	98146-scientific-misconduct-check.png
Scientific Editor Work List	98146-scientific-editor-work-list.pdf
CrossCheck Report	98146-crosscheck-report.pdf
CrossCheck Report	98146-crosscheck-report.png